HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ibopamine: a new preoperative mydriatic for cataract surgery.

Abstract
Ibopamine is a dopaminergic mydriatic of proven use for fundoscopy. This double-blind prospective trial assessed its efficacy and safety as a preoperative mydriatic agent. 105 patients undergoing extracapsular cataract surgery were randomly allocated to receive Ibopamine 1%, Ibopamine 1% with Cyclopentolate 1%, or the control Phenylephrine 10% with Cyclopentolate 1%. Ibopamine alone achieved good mydriasis prior to anaesthesia, but this was not maintained intraoperatively. Cyclopentolate combined with Ibopamine, produced consistently greater mydriasis than when combined with Phenylephrine, but the difference became less marked as surgery continued. Analysis in relation to the stage of surgery showed that the greatest stimulus to miosis occurred during expression of the nucleus. Pulse rate and blood pressure in the 51 local anaesthetic cases showed no significant difference between the treatment groups, and there was no significant variation from baseline. The incidence of local side effects was similar in the three groups, and there were no systemic symptoms attributable to the drops. In conclusion, Ibopamine is a safe and effective mydriatic agent for cataract surgery, when used in combination with Cyclopentolate.
AuthorsM C Corbett, S A Buckley, A B Richards
JournalEuropean journal of ophthalmology (Eur J Ophthalmol) 1994 Jan-Mar Vol. 4 Issue 1 Pg. 29-34 ISSN: 1120-6721 [Print] United States
PMID7912576 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Dopamine Agents
  • Ophthalmic Solutions
  • Phenylephrine
  • ibopamine
  • Cyclopentolate
  • Deoxyepinephrine
Topics
  • Aged
  • Cataract Extraction
  • Cyclopentolate (administration & dosage)
  • Deoxyepinephrine (administration & dosage, analogs & derivatives)
  • Dopamine Agents (administration & dosage)
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Humans
  • Iris (drug effects)
  • Lenses, Intraocular
  • Male
  • Ophthalmic Solutions
  • Phenylephrine (administration & dosage)
  • Prospective Studies
  • Pupil (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: